Abstract
We investigated the effect of cyanide 3-chlorophenylhydrazone (CCCP) and other efflux pump inhibitors (EPIs) on the colistin susceptibility in Acinetobacter baumannii. While minimum inhibitory concentrations (MICs) of colistin in all colistin-resistant strains decreased significantly with 25 μM of CCCP and 2,4-dinitrophenol (DNP), phenyl-arginine-β-naphthylamide (PAβN), and reserpine did not decrease the colistin MICs. However, CCCP and DNP as well as PAβN and reserpine did not have a significant effect on the MICs of the other agents. Efflux pump gene expressions in colistinresistant strains were not increased compared with those in colistin-susceptible strains. When only 5X MIC of colistin (5 mg/L) was provided to a colistin-susceptible A. baumannii strain, the bacterial cell number was reduced by 9 h after exposure to colistin, but regrowth was observed. When CCCP was added to colistin, bacterial cells were completely killed after 24 to 48 h of incubation, which was not due to the toxicity of CCCP itself. Colistin resistance in A. baumannii may not be due to efflux pumps. Our present study suggests that bacterial cells with reduced metabolic activity by CCCP are more susceptible to colistin in A. baumannii. It may show the possibility that combined therapy with colistin and other antimicrobial agents could effective against A. baumannii infections.
Similar content being viewed by others
References
Adams, M.D., Nickel, G.C., Bajaksouzian, S., Lavender, H., Murthy, A.R., Jacobs, M.R., and Bonomo, R.A. 2009. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 53, 3628–3634.
Alteri, C.J., Lindner, J.R., Reiss, D.J., Smith, S.N., and Mobley, H.L.T. 2011. The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli. Mol. Microbiol. 82, 145–163.
Bengoechea, J.A. and Skurnik, M. 2000. Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia. Mol. Microbiol. 37, 67–80.
Clinical and Laboratory Standards Institute (CLSI). 2013. Performance Standards for Antimicrobial Susceptibility Testing, Twenty-First Informational Supplement. CLSI Document M100-S23. Clinical and Laboratory Standards Institute, Wayne PA, USA.
Falagas, M.E., Fafailidis, P.I., and Matthaiou, D.K. 2010. Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist. Updates 13, 132–138.
Fournier, P.E. and Richet, H. 2006. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin. Infect. Dis. 42, 692–699.
Landman, D., Georgescu, C., Martin, D.A., and Quale, J. 2008. Polymyxins revisited. Clin. Microbiol. Rev. 21, 449–465.
Lee, H., Hsu, F.F., Turk, J., and Groisman, E.A. 2004. The PmrAregulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica. J. Bacteriol. 186, 4124–4133.
Moffatt, J.H., Harper, M., Harrison, P., Hale, J.D., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St Michael, F., Cox, A.D., et al. 2010. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide. Antimicrob. Agents Chemother. 54, 4971–4977.
Munoz-Price, L.S. and Weinstein, R.A. 2008. Acinetobacter infection. N. Engl. J. Med. 358, 1271–1281.
Nakajima, Y. 1999. Mechanisms of bacterial resistance to macrolide antibiotics. J. Infect. Chemother. 5, 61–74.
Nation, R.L. and Li, J. 2009. Colistin in the 21st century. Curr. Opin. Infect. Dis. 22, 535–543.
Owen, R.J., Li, J., Nation, R.L., and Spelman, D. 2007. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates. J. Antimicrob. Chemother. 59, 473–477.
Pamp, S.J., Gjermansen, M., Johansen, H.K., and Tolker-Nielsen, T. 2008. Tolerance to the antimicrobial peptide colisitn in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol. Microbiol. 68, 223–240.
Park, Y.K., Choi, J.Y., Shin, D., and Ko, K.S. 2011. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents 37, 525–530.
Peleg, A.Y., Adams, J., and Paterson, D.L. 2007. Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51, 2065–2069.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, Y.K., Ko, K.S. Effect of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on killing Acinetobacter baumannii by colistin. J Microbiol. 53, 53–59 (2015). https://doi.org/10.1007/s12275-015-4498-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-015-4498-5